静脉窦支架置入降低特发性颅内压增高患者颅内压:一项前瞻性先导研究
这项前瞻性先导研究纳入10例药物治疗失败的特发性颅内压增高(IIH)患者,对存在静脉窦狭窄且跨狭窄压力梯度升高者行支架置入。支架置入后狭窄及压力梯度消失,颅内压(ICP)即刻及过夜均下降,全部患者主观与客观症状改善,随访中位23.4个月时除1例外均改善。作者结论认为,对经选择的IIH伴静脉窦狭窄、压力梯度升高且ICP升高的患者,静脉窦支架置入可消除静脉压力梯度、降低ICP并带来功能、神经及眼科改善;因存在支架邻近狭窄风险,需进一步随访以确定长期结局并理解静脉窦狭窄是ICP升高的原发还是继发过程。
要点
- 10例药物治疗失败的IIH患者中,存在静脉窦狭窄且跨狭窄压力梯度升高者接受静脉窦支架置入。
- 支架置入后狭窄与压力梯度消失(1 ± 1 mm Hg),ICP由42.2 ± 15.9 mm Hg降至17.0 ± 8.3 mm Hg、过夜降至8 ± 4.2 mm Hg。
- 2例出现支架邻近狭窄,再次治疗后狭窄与梯度均消除。
核心结论
- 对经选择的IIH伴静脉窦狭窄、跨狭窄压力梯度升高且ICP升高的患者,静脉窦支架置入可消除静脉压力梯度、降低ICP并带来功能、神经及眼科改善。
- 因患者存在支架邻近狭窄风险,需进一步随访以确定长期结局并理解静脉窦狭窄是ICP升高的原发还是继发病理过程。
研究设计与样本
- 前瞻性先导研究,纳入10例药物治疗失败的特发性颅内压增高(IIH)患者。
- 经MR血管成像发现静脉窦狭窄者进一步行导管血管造影、静脉造影评估压力梯度及ICP监测。
- ICP升高且跨狭窄压力梯度升高者接受支架置入。
主要发现
- 所有患者静脉压升高(均值39.5 ± 14.9 mm Hg),跨静脉窦狭窄压力梯度升高(30.0 ± 13.2 mm Hg),ICP升高(42.2 ± 15.9 mm Hg)。
- 支架置入后所有患者狭窄及压力梯度消除(1 ± 1 mm Hg);ICP即刻降至均值17.0 ± 8.3 mm Hg,过夜进一步降至均值8 ± 4.2 mm Hg。
- 所有患者主观和客观改善,随访(中位23.4个月;范围15.7-31.6个月)期间除1例外均改善。
- 2例出现支架邻近狭窄,再次治疗使两例的狭窄和压力梯度均消除。
- 以视乳头水肿起诊者随访眼底成像和光学相干断层扫描(OCT)显示消退、视野检查改善;以视神经萎缩起诊者随访OCT显示视神经变薄,但视野改善。
局限性
- 原文在结论中写明患者存在支架邻近狭窄风险,需进一步随访以确定长期结局并理解静脉窦狭窄是ICP升高的原发还是继发病理过程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Idiopathic intracranial hypertension (IIH) may cause blindness due to elevated intracranial pressure (ICP). Venous sinus stenosis has been identified in select patients, leading to stenting as a potential treatment, but its effects on global ICP have not been completely defined. The purpose of this pilot study was to assess the effects of venous sinus stenting on ICP in a small group of patients with IIH. METHODS Ten patients for whom medical therapy had failed were prospectively followed. Ophthalmological examinations were assessed, and patients with venous sinus stenosis on MR angiography proceeded to catheter angiography, venography with assessment of pressure gradient, and ICP monitoring. Patients with elevated ICP measurements and an elevated pressure gradient across the stenosis were treated with stent placement. RESULTS All patients had elevated venous pressure (mean 39.5 ± 14.9 mm Hg), an elevated gradient across the venous sinus stenosis (30.0 ± 13.2 mm Hg), and elevated ICP (42.2 ± 15.9 mm Hg). Following stent placement, all patients had resolution of the stenosis and gradient (1 ± 1 mm Hg). The ICP values showed an immediate decrease (to a mean of 17.0 ± 8.3 mm Hg), and further decreased overnight (to a mean of 8 ± 4.2 mm Hg). All patients had subjective and objective improvement, and all but one improved during follow-up (median 23.4 months; range 15.7-31.6 months). Two patients developed stent-adjacent stenosis; retreatment abolished the stenosis and gradient in both cases. Patients presenting with papilledema had resolution on follow-up funduscopic imaging and optical coherence tomography (OCT) and improvement on visual field testing. Patients presenting with optic atrophy had optic nerve thinning on follow-up OCT, but improved visual fields. CONCLUSIONS For selected patients with IIH and venous sinus stenosis with an elevated pressure gradient and elevated ICP, venous sinus stenting results in resolution of the venous pressure gradient, reduction in ICP, and functional, neurological, and ophthalmological improvement. As patients are at risk for stent-adjacent stenosis, further follow-up is necessary to determine long-term outcomes and gain an understanding of venous sinus stenosis as a primary or secondary pathological process behind elevated ICP.
引用
- Liu KC, Starke RM, Durst CR, et al. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study. J Neurosurg. 2016. PMID: 28009240. doi:10.3171/2016.8.JNS16879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。